This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $4,325.35, is for the delivery of ADALIMUMAB-ADBM(CF) 40 MG SYRGS, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $90,654.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The contract covers the supply of ADALIMUMAB 2PPN 2S, a pharmaceutical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a Ceiling Value of $16,373.81. The contract is for the supply of ADALIMUMAB 2PPN 2S, a pharmaceutical product, and is a Firm Fixed Price contract. There is no Set-Aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $6,983.82 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ADALIMUMAB 2PPN 2S pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,310.74 delivery order contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL medication. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
This federal contract award is for the delivery of Humira (adalimumab) 40 mg/0.4 mL syringes to the Defense Logistics Agency (DLA). The $2,110.49 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a completion date of February 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,946.52 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company based in Conshohocken, Pennsylvania. The contract is for the supply of the specialty drug Adalimumab-FKJP (CF) Pen 40 MGs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $126,158.40 contract is for the supply of adalimumab, a pharmaceutical product, to support military treatment programs and facilities. The contract has a performance period ending on October 6, 2017 and does not have a set-aside designation. Amerisourcebergen Drug Corp has a history of providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,750.94 firm-fixed-price delivery order is for the supply of the pharmaceutical product Humira (adalimumab) in the 40 mg/0.4 mL dosage form. The contract has a performance period ending on May 7, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Humira (adalimumab) pharmaceutical products, with a total ceiling value of $4,787.28. The contract is a Firm Fixed Price Delivery Order with a final completion date of November 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...